An Observational Study on the Use of 5% EOI Foam for Esophageal Varices Sclerotherapy

An Observational Study on the Use of 5% EOI Foam for Esophageal Varices Sclerotherapy - An Observational Study on the Use of 5% EOI Foam for Esophageal Varices Sclerotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052885

Enrollment

100

Registered

2023-11-23

Start date

2023-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with esophageal varices

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the following criteria, 1) or 2), are eligible. 1) Patients who are eligible for EIS treatment using the 5% EOI form for esophageal varices 2) Patients who were treated with EIS using the 5% EOI or 5% EOI form for esophageal varices between 1/1/2009 and 7/30/2023 and who did not refuse participation in the opt-out document.

Exclusion criteria

Exclusion criteria: Persons who fall into any of the following categories 1) Those who have expressed their refusal to participate in this study through a release of information document. 2) Other patients who are judged by the investigator or subinvestigator to be unsuitable for the safe conduct of this study.

Design outcomes

Primary

Measure	Time frame
Recurrence rate of esophageal varices at 6 months after EIS treatment Definition of recurrence: esophageal varices morphology F1 or higher or RC sign on endoscopy after treatment.	—

Countries

Japan

Contacts

Public ContactHidemi Unozawa

Chiba University Hospital Gastroenterology

unozawa.hidemi@chiba-u.jp43222717

Outcome results